代償性肝硬変、代償期肝硬変
WordNet
- make amends for; pay compensation for; "One can never fully repair the suffering and losses of the Jews in the Third Reich"; "She was compensated for the loss of her arm in the accident" (同)recompense, repair, indemnify
- adjust for; "engineers will work to correct the effects or air resistance" (同)counterbalance, correct, make_up, even out, even off, even up
- make payment to; compensate; "My efforts were not remunerated" (同)recompense, remunerate
- a chronic disease interfering with the normal functioning of the liver; the major cause is chronic alcoholism (同)cirrhosis of the liver
- receiving or eligible for compensation; "salaried workers"; "a stipendiary magistrate" (同)remunerated, salaried, stipendiary
PrepTutorEJDIC
- (…に対して)〈人〉‘に'『補償する』《+『名』+『for』+『名』》 / 〈損失など〉'を'『償う』 / 《米》…‘に'報酬(給与)を支払う / (損失などを)『償う』《+『for』+『名』》
- 肝硬変
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Effect of Fuzheng Huayu capsule combined with Pegasys on genotype 1 hepatitis C fibrosis and cell apoptosis.
- Zhang B, Hu M, Huang L, Pu Y, Pei H, Hua Z, Yao S.
- Experimental and therapeutic medicine.Exp Ther Med.2014 Oct;8(4):1123-1126. Epub 2014 Aug 8.
- The aim of the present study was to observe the effects of Fuzheng Huayu capsule combined with Pegasys (peginterferon α-2a) on hepatic fibrosis in rats and in the treatment of patients with genotype 1 hepatitis C and hepatic cirrhosis. A dimethylnitrosamine (DMN)-induced rat model of liver injury w
- PMID 25187808
- Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B.
- Jia YX1, Cui FQ, Li L, Zhang DL, Zhang GM, Wang FZ, Gong XH, Zheng H, Wu ZH, Miao N, Sun XJ, Zhang L, Lv JJ, Yang F.
- Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation.Qual Life Res.2014 Oct;23(8):2355-63. doi: 10.1007/s11136-014-0670-3. Epub 2014 Mar 14.
- OBJECTIVES: The purpose of the study was to compare psychometric properties of the EQ-5D-5L (5L) and the EQ-5D-3L (3L) health outcomes assessment instruments in patients with hepatitis B in China.METHODS: Patients, including hepatitis B virus carriers and those with active or inactive chronic hepati
- PMID 24627090
- Using Pharmacokinetic and Viral Kinetic Modeling To Estimate the Antiviral Effectiveness of Telaprevir, Boceprevir, and Pegylated Interferon during Triple Therapy in Treatment-Experienced Hepatitis C Virus-Infected Cirrhotic Patients.
- Laouénan C1, Marcellin P2, Lapalus M3, Khelifa-Mouri F4, Boyer N4, Zoulim F5, Serfaty L6, Bronowicki JP7, Martinot-Peignoux M3, Lada O3, Asselah T2, Dorival C8, Hézode C9, Carrat F10, Nicot F11, Peytavin G12, Mentré F13, Guedj J14.
- Antimicrobial agents and chemotherapy.Antimicrob Agents Chemother.2014 Sep;58(9):5332-41. doi: 10.1128/AAC.02611-14. Epub 2014 Jun 30.
- Triple therapy combining a protease inhibitor (PI) (telaprevir or boceprevir), pegylated interferon (PEG-IFN), and ribavirin (RBV) has dramatically increased the chance of eradicating hepatitis C virus (HCV). However, the efficacy of this treatment remains suboptimal in cirrhotic treatment-experienc
- PMID 24982076
Japanese Journal
- Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C
- 生体部分肝移植後早期に妊娠出産し得た胆道閉鎖症の1例
- 高齢(>75歳)のC型慢性肝疾患患者に於けるDAA 2剤(DCV+ASV)治療の有効性
Related Links
- I have just been diagnosed with stage 1-2 of compensated cirrhosis. I was also told that there was nothing they could do to treat it and it would progress into decompenstated cirrhosis. At that tim...
- Cirrhosis Symptoms: Compensated Cirrhosis Symptoms. The Cirrhosis Blog, Cures, Treatments, and Remedies to heal your cirrhosis. ... In cirrhosis I generally administered solely in the respective treatment. The data reveals the ...
Related Pictures
★リンクテーブル★
[★]
- 英
- compensated cirrhosis
- 関
- 代償期肝硬変
[★]
- 英
- compensated cirrhosis
- 関
- 代償性肝硬変
[★]
- 関
- compensation、price
[★]
- cirrho(=tawny yellow)
[★]
- 関
- compensatory